PEG-G-CSF

DRUG4 trials

Sponsors

Dong-A ST Co., Ltd., Sanofi, Shandong University

Conditions

Acute Myeloid LeukemiaChemotherapy Induced NeutropeniaProstate Cancer

Phase 2

Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

CompletedNCT01923545

Dong-A ST Co., Ltd.Chemotherapy Induced Neutropenia

Start: 2010-07-31End: 2011-05-31Updated: 2014-10-01

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients

Shandong UniversityAcute Myeloid Leukemia

Start: 2017-01-31End: 2020-07-31Target: 120Updated: 2017-02-07

Phase 3

Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

CompletedNCT01674855

Dong-A ST Co., Ltd.Chemotherapy Induced Neutropenia

Start: 2012-02-29End: 2013-05-31Target: 74Updated: 2014-10-01

Phase 4

Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer

CompletedNCT02441894

SanofiProstate Cancer

Start: 2015-04-30End: 2016-11-30Updated: 2017-01-24

Related Papers

Impact of pegfilgrastim as primary prophylaxis for metastatic castration-resistant prostate cancer patients undergoing cabazitaxel treatment: an open-label study in Japan.

2019-08-019 citations